search
Back to results

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy (PALLM)

Primary Purpose

Myoma

Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Hyalobarrier
Sponsored by
University Hospital, Ghent
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myoma focused on measuring Postoperative adhesions, Intrauterine adhesions, Myomectomy, Laparoscopic myomectomy, Laparotomic myomectomy, Adhesion prevention, Antiadhesion method

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: age between 18 and 45 years. intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy. absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy Exclusion Criteria: pregnancy. laparoscopic or laparotomic myomectomy in combination with an operative hysteroscopy. presence of endometritis. other antiadhesion methods

Sites / Locations

  • University Hospital GhentRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

intrauterine gel application

no intra-uterine gel application

Arm Description

Application of Hyalobarrier intrauterine after myomectomy.

No application of Halobarrier intrauterine after myomectomy.

Outcomes

Primary Outcome Measures

Adhesion formation postoperatief.
The presence of intra-uterine adhesions on a second look hysteroscopy.

Secondary Outcome Measures

Severity of adhesion formation
American Fertility Society classification (AFS) and classification of Valle and Sciarra are used to describe the severity.

Full Information

First Posted
December 20, 2022
Last Updated
May 4, 2023
Sponsor
University Hospital, Ghent
Collaborators
Nordic Pharma SAS
search

1. Study Identification

Unique Protocol Identification Number
NCT05683041
Brief Title
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Acronym
PALLM
Official Title
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 22, 2023 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent
Collaborators
Nordic Pharma SAS

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy. Myomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.
Detailed Description
Design: Double-blind, randomized controlled pilot trial. Participant: age between 18 and 45 years. intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy. absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy Treatment: Application of intrauterine Hyalobarrier® gel endo at time of surgery Control: No application of Hyalobarrier® gel endo Follow up: Second-look hysteroscopy after 3months To blind all trial participants and gynaecologists doing second-look hysteroscopy, 10 ml of a sterile ultrasound gel will be applied into the vagina at the end of the procedure in all women regardless of their treatment allocation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myoma
Keywords
Postoperative adhesions, Intrauterine adhesions, Myomectomy, Laparoscopic myomectomy, Laparotomic myomectomy, Adhesion prevention, Antiadhesion method

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions. The application of antiadhesion gel is compared to no gel.
Masking
ParticipantCare ProviderInvestigator
Masking Description
None of the participants will be informed of the allocated treatment by the surgeon or the personnel present in the OR. The medical record will not reveal any information whether antiadhesion gel was applied at the end of the procedure. In the case that the surgeon is the same person as the gynaecologist doing the second-look hysteroscopy, blinding is assured by notification of treatment allocation if the surgeon has left the operating room.
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
intrauterine gel application
Arm Type
Experimental
Arm Description
Application of Hyalobarrier intrauterine after myomectomy.
Arm Title
no intra-uterine gel application
Arm Type
No Intervention
Arm Description
No application of Halobarrier intrauterine after myomectomy.
Intervention Type
Device
Intervention Name(s)
Hyalobarrier
Other Intervention Name(s)
anti-adhesive gel
Intervention Description
Hyalobarrier is a viscous, transparent gel and is used as a preventive measure for post-operative adhesions in the abdominal and uterine cavity.
Primary Outcome Measure Information:
Title
Adhesion formation postoperatief.
Description
The presence of intra-uterine adhesions on a second look hysteroscopy.
Time Frame
3 months post surgery
Secondary Outcome Measure Information:
Title
Severity of adhesion formation
Description
American Fertility Society classification (AFS) and classification of Valle and Sciarra are used to describe the severity.
Time Frame
3 months post surgery, at the time of the hysteroscopy.

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
only woman included with uterus.
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age between 18 and 45 years. intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy. absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy Exclusion Criteria: pregnancy. laparoscopic or laparotomic myomectomy in combination with an operative hysteroscopy. presence of endometritis. other antiadhesion methods
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Steffi Van Wessel, Dr.
Phone
093320758
Email
studieco.vrouwenkliniek@uzgent.be
First Name & Middle Initial & Last Name or Official Title & Degree
Steven Weyers, Prof. dr.
Phone
093320758
Email
studieco.vrouwenkliniek@uzgent.be
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steffi van Wessel, Dr.
Phone
093320758
First Name & Middle Initial & Last Name & Degree
Steven Weyers, Prof. Dr.
Phone
093320758
First Name & Middle Initial & Last Name & Degree
Steffi van Wessel

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy

We'll reach out to this number within 24 hrs